EMA expands inquiry into suicidal thoughts linked to GLP-1 weight loss drugs
HQ Team December 2, 2023: The European Medicines Agency (EMA) is intensifying its investigation into the potential link between certain GLP-1 receptor agonist
HQ Team December 2, 2023: The European Medicines Agency (EMA) is intensifying its investigation into the potential link between certain GLP-1 receptor agonist
HQ Team November 2, 2023: A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut
HQ Team December 2, 2023: Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50%
HQ Team December 1, 2023: The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in
HQ Team December 1, 2023: The full year 2023 is set to be the warmest on record with global temperatures rising 1.4 degrees
HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating
HQ Team November 30, 2023: AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to
HQ Team November 30, 2023: Rush hour traffic is an everyday reality for most city dwellers. Adding to the frustration of being stuck
HQ Team November 30, 2023: The COP28 has reached an agreement to operationalise a fund, known as ‘loss and damage’ to aid developing
HQ Team November 30, 2023: Postpartum depression is a common psychological affliction following childbirth and affects 17.22% of the world population. Postpartum depression